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In lymphocytes cap formation induced by concanavalin A (con A) was 
found to be concentration dependent on the mitogen in the presence of 
colchicine, a microtubule disrupting agent. The dose-respone of cap forma- 
tion under these conditions was similar to mitogen dose-response. In 
addition, a direct correlation was found between con A capping induced 
in the presence of colchicine and mitogenic responses with con A alone. 
Agents such as dibutyryl cyclic AMP, which suppress mitogenic responses, 
decrease capping. Zinc increases capping when it causes enhancement of 
mitogenesis and decreases capping when it suppresses mitogenic response. 
These observations are interpreted on the basis of a model in which binding 
of con A to surface receptors leads to formation of microfilaments, which 
might be essential for capping as well as the initiation of DNA synthesis. 
Thus, the experimental observations in this report lend support to a model 
implicating the formation of microfilaments as a crucial event in triggering 
a variety of cellular responses following ligand binding. 
Introduction 
Interaction of ligands with surface receptors of lymphocytes leads to rapid 
changes in the surface membrane and polarization of receptors leading to 
what is termed “cap” formation. Treatment of human peripheral blood 
lymphocytes (PBL) with fluoresceinated concanavalin A (F-con A) at 37°C 
induces cap formation in a small percentage of lymphocytes. Cap formation 
can be affected by cytoskeletal modulating agents such as colchicine (de 
Petris, 1974; Albertini, Berlin & Oliver, 1977), cytochalasin B (de Petris, 
1974; Yahara & Edelman, 1975) and lidocaine (Poste, Papahadjopoulos 
& Nicolson, 1975). The above observations suggest that the cell surface 
receptors interact with microtubules and microfilaments and disruption of 
these elements lead to alterations in surface receptor mobility (Yahara & 
Edelman, 1975). Further, it is proposed that mitogenic stimulation of 
lymphocytes might involve formation of microaggregates of receptors on 
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the surface and the propagation of the signal into the cytoplasm and the 
nucleus of the cell through cytoskeletal structures (Edelman, 1974). 
In order to study the relationship between the con A-induced capping 
and con A-induced mitogenic responses, experiments were done to examine 
capping and mitogenic responses with the same preparation of con A 
simultaneously, in the presence of various drugs. Our data indicate that 
the con A-induced capping in the presence of colchicine demonstrates 
a direct correlation with mitogenic responses induced by con A alone. 
Further, it is demonstrated that agents which enhance mitogenic responses 
increase capping and agents which suppress mitogenic responses decrease 
capping. On the basis of these observations a model is presented to explain 
the relationship between capping and mitogenic responses. 
Materials and Methods 
Donors. Blood from young, healthy volunteers was freshly obtained from 
a peripheral vein. All donors gave informed consent consistent with the 
regulations of The University of Michigan and Department of Health and 
Human Services. The donor population ranged in age between 22-35 years. 
Isolation of Mononuclear Cells. Mononuclear cells were prepared from 
fresh heparinized blood (20 U/ml) by Ficoll-Hypaque density gradient 
technique. The cells were washed three times with Ca2+ and Mg*+ free 
Hanks’ balanced salt solution (HBSS, Grand Island Biological Co., Grand 
Island, N.Y.) and resuspended in RPM1 1640 medium (Grand Island 
Biological Co.). 
Chemicals. Colchicine and N6, 02’ -dibutyryl adenosine 3’ : 5’ cyclic 
monophosphoric acid (DbcAMP) were obtained from Sigma Chemical Co., 
St. Louis, Missouri. ZnC12 was obtained from Fisher Scientific Co., New 
Jersey. F-con A was obtained from Calbiochem-Behring Corporation, 
LaJolla, California. It had a fluorescein/protein ratio (molar) of 5.7. Methyl- 
C3H]Thymidine ([3H]Thymidine), specific activity 6.7 ci/mmol was obtained 
from New England Nuclear, Boston, Massachusetts. 
MITOGENIC EXPERIMENTS 
Cells were cultured in 96 well round bottom microtiter plates at a 
concentration of 50 000 cells in 100 ~1 of culture medium. The culture 
medium consisted of 10% heat inactivated fetal calf serum, 2 *M fresh 
glutamine and 50 t.r.g gentamicin per ml (Schering Corp., Kenilworth, New 
Jersey) in RPM1 1640. F-con A and drugs were added directly to the wells 
and the final volume was adjusted to 120 ~1. The cells were incubated for 
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72 hr at 37°C in an atmosphere consisting of 5% CO2 and 95% air. At 
the end of 72 hr, 2 &i of [3H] Thymidine was added to each well and 
incubated for an additional 18 hr. The cells were harvested with an auto- 
matic cell harvester (Flow Laboratories, Rockville, Maryland) and r3H] 
Thymidine incorporation was measured by liquid scintillation counting. 
Cultures were set-up in triplicate and the data were expressed as mean 
*SEM. 
CAPPING EXPERIMENTS 
Mononuclear cells were suspended at a concentration of 4-6 x lo6 
cells/ml in RPM1 1640 and 0.5 ml of the suspension was used for each 
experiment. Drugs were added to the cells and incubated for 30 minutes 
at 37°C with continuous rotation. Then F-con A was added and incubated 
for another 30 minutes. At the end of incubation the cells were fixed with 
0.5 ml of 2% paraformaldehyde for 10 minutes, washed twice with HBSS 
and the number of caps formed was enumerated under fluorescence micro- 
scopy. One hundred fluorescent labelled cells were counted and the number 
of caps was expressed as a percentage of a total of one hundred cells 
including the caps. The tubes were coded and read blindly to avoid observer 
bias. 
Results 
EFFECTS OF COLCHICINE ON CAPPING 
Table I shows the number of caps formed at various concentrations of 
con A with and without colchicine (lo-’ M, final concentration). The num- 
ber of caps formed with con A alone is small and it is difficult to attribute 
any significance to the small differences noted. But in the presence of 
colchicine the numbers of caps are increased and a distinct concentration 
effect becomes evident. Further, the dose-response of the capping appears 
TABLE 1 
Efect of con A concentration on capping with and 
without colchicine 
Con A Caps (% ) 
bdml) No colchicine Colchicine (10e5 M) 
30 6 30 
20 5 28 
10 8 42 
5 6 22 
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remarkably similar to the mitogen dose-response curves. This observation 
prompted me to perform dose-responses of con A-induced capping with 
colchicine and compare it with mitogenic responses with con A alone. 
F-con A was used for both capping as well as mitogenic experiments. 
CORRELATION BETWEEN COLCHICINE INDUCED CAPPING 
AND MITOGENIC RESPONSES 
Figure 1 shows the correlation between con A capping induced in the 
presence of colchicine and the mitogenic responses using the same con- 
centrations of F-con A. A direct correlation between the number of caps 
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FIG. 1. Correlation between con A-capping induced in the presence of colchicine and 
mitogenic responses induced by con A alone. A = caps (%); 0 = c.p.m. x 10e3. 
EFFECTS OF DbcAMP ON CAPPING AND MITOGENIC RESPONSES 
Table 2 shows two representative experiments with DbcAMP (10e4 M, 
final concentration). Capping experiments were performed with colchicine 
and colchicine plus DbcAMP. Cap formation was correlated with con 
A-induced mitogenic responses with and without DbcAMP. In both experi- 
ments suppression of capping was associated with suppression in mitogenic 
responses. 
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TABLE 2 
Efects of dibutyryl cyclic AMP on capping and mitogenic responses induced 
by con A 
Con A 
&dmU 
Caps (%) [3H] - Thymidine incorporation (c.p.m.) 



















26 422* 5160t 5465k 432 
57 152* 6334 15 841k 944 
75 387 f 4696 17 599 f 1420 
64 887+ 10 471 14 232 rt 1904 
59 313k 1659 13 696* 289 
38 590 f 4801 15 336zk 1465 
27 643* 5219 15 624k 1574 
EFFECTS OF ZINC ON CAPPING AND MITOGENIC RESPONSES 
In contrast to DbcAMP which affects capping and mitogenic responses 
in a similar fashion at all concentrations of the mitogen tested, the zinc 
effect is concentration dependent on the mitogen. Therefore, a reasonable 
way to correlate capping and mitogenic data in this case would be to 
compare the maximum number of caps formed with and without zinc to 
maximal mitogenic response with and without zinc, ignoring the concentra- 
tion of the mitogen at which these responses occur. Employing such a 
criterion it can be seen from Table 3 that in experiment 1 zinc (10v4 M, 
TABLE 3 
Effects of zinc on capping and mitogenic responses induced by con A 
Con A 
bfdml) 
Caps (%) [3H] - Thymidine incorporation (c.p.m.) 
No Zinc Zinc No Zinc Zinc 









52 51 59313*1659” 75 296* 20 325 
44 55 38 590*4801 79 299zt 12 258 
46 41 27 643*5219 42 942 f 4739 
56 47 33 908 f 2388 27498* 1103 
45 42 27991*2257 15 947* 1099 
43 43 25 074 f 2309 18 020* 3769 
’ Mean f SEM of triplicates 
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final concentration) causes an increase in the number of caps and there is 
a corresponding increase in the mitogenic response and in experiment 2 
there is a decrease in the number of caps and there is a corresponding 
decrease in the mitogenic response. 
Discussion 
This study was undertaken to examine if the changes associated with 
lectin binding to surface receptors, such as capping, have any relationship 
to the mitogenic responses induced by these agents. It is well established 
that pretreatment of lymphocytes with colchicine, a microtubule disrupting 
agent, enhances con A-induced capping (de Petris, 1974; Albertini et al, 
1977). This has been interpreted to mean that microtubules have an 
anchoring effect on the surface receptors and prevent their mobility. Pre- 
treatment of lymphocytes with cytochalasin B, on the other hand, prevents 
cap formation indicating that the microfilament function is essential for 
cap formation (de Petris, 1974; Yahara & Edelman, 1975). Colchicine and 
cytochalasin B can also modify con A-induced mitogenic responses (Yahara 
& Edelman, 1975; Medrano, Piras & Mordoh, 1974). It was proposed that 
mitogenic stimulation of lymphocytes might involve formation of micro- 
aggregates of receptors on the surface and propagation of the signal into 
the cytoplasm and the nucleus of the cell through cytoskeletal structures 
(Edelman, 1974). In this report, evidence is presented that, under certain 
conditions, there is a direct correlation between capping and mitogenic 
responses. Advantage was taken of the fact that colchicine enhances capping 
and that in the presence of this drug capping becomes a con A-concentration 
dependent phenomenon. 
Exogenous CAMP has been shown to suppress mitogenic responses 
induced by lectins (Smith, Steiner & Parker, 1971). The experiments 
indicate that Dbc AMP, in the presence of colchicine, can also suppress 
capping. It was shown that in the amoeba, Dictyostelium discoideum, plasma 
membrane fragments contain a large amount of actin and myosin following 
con A binding. The author concludes that the ATP-dependent sliding of 
membrane associated actin and myosin filaments may be responsible for 
the accumulation of con A receptor complexes into a cap on the cell surface 
(Condeelis, 1979). ATP plays an important role in the polymerization of 
actin (Lin et aE., 1980); nascent actin chains are shown to be substrates for 
cyclic AMP-dependent phosphorylation (Steinberg, 1980). Mitogenic 
stimulation of lymphocytes activates cyclic AMP-dependent protein kinase 
(Klimpel et al. 1979), and phosphorylation of a number of proteins takes 
place within minutes following the mitogenic stimulation (Chaplin, Wedner 
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& Parker, 1980). It has been shown that phosphorylated platelet myosin 
has higher actin activation than unphosphorylated myosin (Adelstein & 
Conti, 1975). Similarly phosphorylation of the 20 000 m.w. light chain of 
gizzard myosin is required for optimal actin activation (Gorecka, Askoy 
& Hartshorne, 1976; Askoy et al., 1976). These observations suggest a 
close interaction between cyclic AMP, actin microfilament formation and 
mitogenic responses. 
The effects of zinc on capping and mitogenic responses induced by con 
A are also of great interest. Zinc has variable effects on mitogenic responses, 
causing enhancement in some cases and suppression in others (Rao, 
Schwartz & Good, 1979). Previous studies indicate that the site of action 
of zinc is likely to be microfilaments and that zinc does not have an effect 
on colchicine sensitive structures (Rao & Schwartz, 1980). In the present 
experiments with zinc, enhancement of capping was associated with 
enhanced mitogenic responses and decrease in the capping was associated 
with suppressed mitogenic responses. Thus, it appears that mitogenic 
responses of lymphocytes are directly related to the capping process, 
induced in the presence of colchicine. 
However, it should be noted that the correlation between the capping 
and the mitogenic responses is artificial. The conditions under which capping 
and mitogenic responses performed are different. Colchicine was not pres- 
ent in mitogenic experiments, because at a concentration of lo-’ M, col- 
chicine completely inhibits mitogenic responses (Medrano et al, 1974; Rao 
& Schwartz, 1980). However, the model proposed below attempts to offer 
a rationale for these experimental observations and explain the relationship 
between capping and mitogenic responses induced by con A. 
It is known that filamentous structures can form rapidly and transiently; 
the contractile ring during mitosis forms shortly before mitosis and disap- 
pears afterwards (Schroeder, 1972). Microfilament bundles form rapidly 
during spreading of fibroblasts and disappear in rounded cells (Goldman, 
1975; Goldman & Knipe, 1973). It has been shown that following reduction 
of microvilli of the small intestine of the salamander, the first step in their 
re-formation was accumulation of a dense material on the cytoplasmic 
surface and filaments then extend from this dense region (Tilney & Cardell, 
1970). Thus, the interaction of microfilaments with the cell membrane 
appears to be a dynamic process. Actin is a major component of microfila- 
ments and the dynamic state of microfilament formation implies that actin 
can rapidly dissociate and associate and that it can exist in a state of 
equilibrium between monomeric and the polymeric state. 
In the present model (Fig. 2) I propose a portion of the actin exists in a 
soluble state in unstimulated lymphocytes. When a lectin binds to a surface 





FIG. 2. A model to explain the relationship between con A-capping induced in the presence 
of colchicine and con A-induced mitogenic responses. (a) The fluid mosaic model of membrane 
structure with con A receptors anchored to microtubules. In unstimulated lymphocyte a 
portion of actin exists in soluble state. Binding of con A induces a conformational change in 
the receptor and the base of the receptor becomes a nucleus for actin polymerization and 
microfilament formation. (b) Polymerization of actin leads to events which finally result in 
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receptor it induces a conformational change in the receptor and the base 
of the receptor becomes a focal point for actin attachment and microfilament 
formation. The fact that only cross linked surface immunoglobulin is found 
attached to actin but not uncrosslinked surface immunoglobulin (Flanagan 
& Koch, 1978) indicates that attachment of actin to surface molecules 
occurs following ligand binding. The process of microfilament formation 
appears to trigger DNA synthesis. Support for the involve- 
ment of microfilaments in DNA synthesis comes from the fact that 
cytochalasin B can modulate DNA synthesis induced by lectins (Hoffman, 
Ferguson & Simmons, 1977; Greene, Parker 6t Parker, 1976). The forma- 
tion of microfiIaments can also lead to a variety of other biological effects, 
one of the effects being cap formation. But treatment of lymphocytes with 
con A alone does not cause capping (capping occurs only in a small 
percentage of human peripheral blood lymphocytes) because the receptor 
movement is restrained by microtubules. However, if microtubules are 
disrupted by colchicine, formation of microfilaments freely proceeds to cap 
formation; under these conditions capping becomes roughly proportional 
to microfilament formation. Thus, the use of colchicine in capping experi- 
ments is a tool for unmasking the microfilament formation that occurs 
following lectin binding. According to this model the crucial element that 
is required for DNA synthesis is microfilament formation; capping is only 
an epiphenomenon as far as DNA synthesis is concerned. But under 
appropriate conditions (i.e., in the presence of colchicine) capping becomes 
a measure of microfilament formation and can be correlated with mitogenic 
responses. Thus, capping and mitogenic responses may be a reflection of 
the same event occurring in the cell, namely the microfilament formation. 
Attempts were made in the past to correlate capping and lymphocyte 
triggering (Loor, 1977) and the general concensus has been that capping 
is unrelated to lymphocyte triggering. This study essentially reaches the 
same conclusion that capping is not related to mitogenesis as a cause and 
effect phenomenon. But in as much as both capping and mitogenic responses 
depend upon microfilament formation (according to the model) a correla- 
tion can be shown under certain conditions. The fact that the cells which 
had bound and capped PHA and con A fail to undergo mitogenesis when 
they were cultured in the absence of lectins was considered as an indication 
that capping is irrelevant to the mitogenic process (Loor, 1974). But if one 
- 
DNA synthesis. Formation of microfilaments can also bring about capping provided the 
anchoring effect of microtubules is removed. Treatment of lymphocytes with colchicine prior 
to con A treatment disrupts microtubules. (c). Under these conditions formation of microfila- 
ments proceeds to cap formation. (d). In the presence of colchicine, capping becomes roughly 
proportional to microfilament formation and can be correlated with mitogenic responses. 
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considers the microfilament formation as the crucial event in the inititation 
of DNA synthesis; the formation of microfilaments being a reversible, 
dynamic event, sustained presence of a lectin in the medium might be 
necessary to keep the actin in a polymerized state (microfilaments) to 
initiate DNA synthesis. 
A model similar to this one based on the assembly of microfilaments 
following ligand-receptor interaction has been proposed to explain the 
stimulus induced secretion in neutrophils (Hoffstein, Korchak & Smolen, 
1981). These models receive strong support from the recent demonstration 
that actin polymerization accompanies thy-l-capping on mouse lym- 
phocytes (Laub, Kaplan & Gitler, 1981). 
Although the model presented is based on the interaction of ligands with 
lymphocyte receptors, the ubiquitous presence of microfilaments in eukary- 
otic cells may make this model applicable to interaction of a variety of 
molecules such as peptide hormones, lymphokines and interferon with 
different cell types. 
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